Considering that IL-8 can promote ovarian cancer progression through several pathways (130–132), it is recommended that further investigation be directed towards the pathways by which metformin mediates its effects on ovarian cancer (129) (Figure 4). This evidence concerns the gene CXCL8 and ovarian cancer.